Is AS Only Important When Severe?

Aortic stenosis (AS) is a progressive disease associated with morbidity and mortality, especially in severe cases. However, recent studies have revealed that moderate stenosis can also have unfavorable consequences in the course of the disease.

¿Solo es importante la estenosis aórtica severa?

One of the challenges lies in that determining its severity is sometimes difficult due to discrepancies between valve area, gradient, and peak velocity, which can lead to confusion regarding the presence of symptoms.

In a study that included 595,120 patients, 70,778 (11.9%) were identified as having some degree of AS. Of them, 48.9% had mild stenosis (L), 8.2% mild to moderate (L/M), 20.6% moderate (M), 5.2% moderate to severe (M/S), and 17.1% severe (S) stenosis.

As AS became more severe, there was an increase in age and risk factors such as hypertension, diabetes, atrial fibrillation, coronary artery disease, heart attack, percutaneous coronary intervention, myocardial revascularization surgery, chronic obstructive pulmonary disease, cancer, ejection fraction lower than 50%, smaller aortic valve area, lower gradient, and higher presence of atrioventricular valve regurgitation.

Read also: Low Gradient, Normal Flow Aortic Stenosis: Changes in Quality of Life with TAVR.

After four years of follow-up, mortality among those who did not receive treatment was 13.5% (95% CI: 13.3%-13.7%) for those without AS, and for those with mild, mild to moderate, moderate, moderate to severe, and severe AS it was 25.0%, 29.7%, 33.5%, 45.7%, and 44.9%, respectively. In those who received treatment, the mortality rate was 0.2%, 1.0%, 4.2%, 11.4%, 36.7%, and 60.7%, respectively.

In an adjusted multivariate analysis, untreated aortic stenosis, regardless of the degree, was associated with an increase in mortality.

Conclusion

In conclusion, patients with aortic stenosis face a significant risk of mortality at all severity levels without treatment. Nevertheless, aortic valve replacement remains low in cases of severe aortic stenosis, indicating the need for further research to understand diagnostic barriers and define the appropriate timing for aortic valve replacement.

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: The Mortality Burden of Untreated Aortic Stenosis. 

Reference: Philippe Généreux, et al. J Am Coll Cardiol 2023;82:2101–2109. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

Left Bundle Branch Block after TAVR: What Is Its Impact?

Courtesy of Dr. Juan Manuel Pérez. Left bundle branch block (LBBB) is a common complication following transcatheter aortic valve replacement (TAVR), which can be either...

Multicenter Experience with 3D Intracardiac Echocardiography for Guiding Interventional Cardiac Procedures

Courtesy of Dr. Juan Manuel Pérez. Imaging techniques play a fundamental role in interventional cardiac procedures. Intracardiac echocardiography (ICE) appears as an alternative to transesophageal...

Pathology of Self-Expanding Transcatheter Aortic Bioprostheses and Hypoattenuated Leaflet Thickening

Courtesy of Dr. Juan Manuel Pérez. Despite the available long term followup data on of transcatheter aortic valve replacement (TAVR), bioprosthesis durability continues under debate....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...